Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-045366
Filing Date
2013-08-16
Accepted
2013-08-16 18:10:51
Documents
1
Period of Report
2013-08-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd388586.html 3  
1 FORM 3 rrd388586.xml 3 1951
  Complete submission text file 0001181431-13-045366.txt   3656
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Issuer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 324 SOUTH HYDE PARK AVE, SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE, SUITE 350 TAMPA FL 33606 813-864-2557
HedgePath, LLC (Reporting) CIK: 0001584617 (see all company filings)

State of Incorp.: FL | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-13467 | Film No.: 131046500